Kriti Nutrients
- Market cap
- ₹ 338 Cr.
- P/E
- 10.1x
- P/B
- 1.45x
- 52-week range
- 51.36 – 102.99
- ROE
- 15%
- ROCE
- 20%
- Dividend yield
- 0%
- Debt / equity
- 0.04
- Sector
- Agricultural Food & other Products
- Industry
- Edible Oil
- Listed on
- NSE, BSE
About
Kriti Nutrients Limited is an India-based soya product manufacturing company. The Company is in the business of soya seed extraction and manufacturing and selling of cooking oil under its own brand KRITI. The Company is engaged in soyabean processing, manufacturing branded refined soyabean, mustard, sunflower and groundnut oil and producing value-added protein-based products. It operates through the Oil Seed Extraction and Refining segment. Its product portfolio includes Kriti oils, lecithin, protein, and acid oil. Its Kriti oils products include refined sunflower oil, refined soybean oil, filtered groundnut oil, and refined mustard oil. It offers a range of lecithin varieties under its brand customized as per customer needs. The Company’s protein products include nuggets/TVP, full fat soya flour, defatted flakes/ grits/ flour toasted, defatted flakes/ grits/ flour untoasted, super hypro SBM, and soya hulls. Its soyabean processing plant is situated in Dewas, Madhya Pradesh (India).
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Edible Oil: 38 companies →Kriti Nutrients against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)10.1 against a typical 18.4: cheaper than most peers (1st = cheapest).7th of 37
- Sales growth+7.9% against a typical +8.9% from a year earlier.16th of 29
- Profit growth−1.6% against a typical +52.5% from a year earlier.19th of 26
- Share price, 3 months−12.2% against a typical −7.4%.25th of 32
- Size₹ 337.7 Cr. market value against a typical ₹ 130.2 Cr. (1st = largest).9th of 31
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A- by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A- / CARE A2+ | Stable | 22 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 22 Sep 2026 | Reaffirmed | CARE A- / CARE A2+ | — | CARE | ₹ 10 Cr. | |
| 9 Sep 2025 | Reaffirmed | CARE A- / CARE A2+ | — | CARE | ₹ 10 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 11 Aug 2026 | Financial Results/Other business matters | Corporate Announcement u/r 29(1)(a) of the SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 regarding intimation of holding 02/2026-27 for consideration and approval of the Un-Audited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2026. |
| 5 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 5 Feb 2026 | Financial Results | Corporate Announcement u/r 29(1)(a) of the SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 regarding intimation of holding 04/2025-26 Board Meeting for consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December, 2025. |
| 8 Nov 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2025 and a Special Dividend on 33rd Anniversary of KRITI refined oil (interim dividend), if any. |
| 12 Aug 2025 | Financial Results | To consider and approve the Un-Audited Standalone & Consolidated Financial Results for the period ended Jun 30, 2025 |
| 22 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 133 | 167 | 172 | 188 | 174 | 173 | 200 | 229 | 213 | 224 | 255 | 247 |
| Expenses | 121 | 148 | 159 | 169 | 161 | 162 | 194 | 218 | 202 | 213 | 246 | 235 |
| Operating Profit | 13 | 19 | 13 | 19 | 12 | 11 | 6 | 11 | 11 | 12 | 9 | 12 |
| OPM % | 9.5% | 11.2% | 7.4% | 9.9% | 7.1% | 6.4% | 3% | 5% | 5.3% | 5.1% | 3.7% | 4.8% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 12 | 19 | 12 | 19 | 13 | 12 | 6 | 12 | 12 | 12 | 9 | 12 |
| Tax % | 21.8% | 24.2% | 28.6% | 24% | 23.8% | 31.4% | 23.1% | 22.4% | 23.8% | 22.3% | 33.3% | 22.8% |
| Net Profit | 10 | 14 | 9 | 14 | 10 | 8 | 5 | 9 | 9 | 9 | 6 | 9 |
| EPS in Rs | 1.95 | 2.83 | 1.75 | 2.85 | 1.91 | 1.65 | 0.99 | 1.84 | 1.84 | 1.84 | 1.24 | 1.81 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 10%
- 5 Years
- 6%
- 3 Years
- 5%
- TTM
- 21%
- 10 Years
- 18%
- 5 Years
- 17%
- 3 Years
- 17%
- TTM
- 5%
- 10 Years
- 16%
- 5 Years
- 11%
- 3 Years
- −1%
- TTM
- —
- 10 Years
- 20%
- 5 Years
- 18%
- 3 Years
- 20%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Kriti Nutrients | ₹ 63.50 | ₹ 338 Cr. | 10.1x | 1.5x | 15% | — |
| Nestle India | ₹ 1,173.45 | ₹ 2,26,278 Cr. | 81.5x | 54.1x | 76.3% | 15.1% |
| Britannia Industries | ₹ 4,547.80 | ₹ 1,09,542 Cr. | 51.3x | 25.8x | 53.6% | 13.3% |
| Tata Consumer Products | ₹ 960.00 | ₹ 95,010 Cr. | 67.6x | 5x | 7.4% | 8.1% |
| Godrej Industries | ₹ 918.00 | ₹ 30,884 Cr. | 35.7x | 4.1x | 11.6% | 10.9% |
| Patanjali Foods | ₹ 351.00 | ₹ 38,193 Cr. | 19x | 2.8x | 14.8% | 4.5% |
Management
- Shiv Singh Mehta
- Executive Chairman of the Board, Joint Managing Director
- Mohan Gehlot
- Chief Financial Officer
- Raj Kumar Bhawsar
- Compliance Officer, Company Secretary
- Saurabh Singh Mehta
- Joint Managing Director, Whole-time Director
Prices are delayed and for information only. Nothing on this page is investment advice.